Pilot Study of Human Tear Proteins

Terminated

• Conditions: Eye Disease

• Registration Number: NCT00453258
• Lead Sponsor: University of Colorado, Denver

Brief Summary

The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film from diseased and non-diseased patients. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-02
• Study First Submitted: 2007-03-26
• Study First Submitted QC: 2007-03-27
• Study First Posted: 2007-03-28
• Primary Completion: 2011-09
• Study Completion: 2011-09
• Status Verified: 2012-10
• Last Update Submitted: 2013-01-15
• Last Update Posted: 2013-01-17

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

• 18 years of age and older
• able to cooperate with tear sample collection
• provide written informed consent

Exclusion Criteria

• special populations (children, pregnant or lactating females, prisoners, etc)
• refusal to sign sudy consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plan Prospective Research	Throughout study participation	Pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Trial Locations

Locations (1)

Rocky Mountain Lions Eye Institute; 🇺🇸 Aurora, Colorado, United States